Correlation Between Health Biotchnology and Mid-cap Profund

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Biotchnology and Mid-cap Profund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Biotchnology and Mid-cap Profund into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Biotchnology Portfolio and Mid Cap Profund Mid Cap, you can compare the effects of market volatilities on Health Biotchnology and Mid-cap Profund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Biotchnology with a short position of Mid-cap Profund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Biotchnology and Mid-cap Profund.

Diversification Opportunities for Health Biotchnology and Mid-cap Profund

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Health and Mid-cap is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Health Biotchnology Portfolio and Mid Cap Profund Mid Cap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mid Cap Profund and Health Biotchnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Biotchnology Portfolio are associated (or correlated) with Mid-cap Profund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mid Cap Profund has no effect on the direction of Health Biotchnology i.e., Health Biotchnology and Mid-cap Profund go up and down completely randomly.

Pair Corralation between Health Biotchnology and Mid-cap Profund

Assuming the 90 days horizon Health Biotchnology Portfolio is expected to under-perform the Mid-cap Profund. But the mutual fund apears to be less risky and, when comparing its historical volatility, Health Biotchnology Portfolio is 1.37 times less risky than Mid-cap Profund. The mutual fund trades about -0.15 of its potential returns per unit of risk. The Mid Cap Profund Mid Cap is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  12,470  in Mid Cap Profund Mid Cap on October 8, 2024 and sell it today you would earn a total of  45.00  from holding Mid Cap Profund Mid Cap or generate 0.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Health Biotchnology Portfolio  vs.  Mid Cap Profund Mid Cap

 Performance 
       Timeline  
Health Biotchnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Biotchnology Portfolio has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Mid Cap Profund 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mid Cap Profund Mid Cap has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Mid-cap Profund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Health Biotchnology and Mid-cap Profund Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Biotchnology and Mid-cap Profund

The main advantage of trading using opposite Health Biotchnology and Mid-cap Profund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Biotchnology position performs unexpectedly, Mid-cap Profund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mid-cap Profund will offset losses from the drop in Mid-cap Profund's long position.
The idea behind Health Biotchnology Portfolio and Mid Cap Profund Mid Cap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios